One of the most memorable lessons during my laboratory posting came from a patient with MGUS and recurrent skin infarcts. Cryoglobulin testing had repeatedly been reported as negative, yet the clinical picture continued to strongly suggest type I cryoglobulinemia. Rather than accepting the negative report at face value, we questioned whether the result could have been affected by the way the sample had been handled. Cryoglobulins are highly temperature-sensitive, and after ensuring the appropriate temperature chain during sample collection, transport and processing, type I cryoglobulinemia was finally demonstrated. This changed the interpretation of the patient’s illness: the monoclonal gammopathy could no longer simply be regarded as incidental MGUS, and the patient was subsequently initiated on myeloma-directed therapy.

This experience captured what I eventually came to understand as one of the most important lessons of my laboratory posting: laboratory medicine is not merely about reading reports; it is about understanding how those reports are generated, recognising when they do not fit the clinical picture, and knowing when to question, repeat or specifically request an investigation.

When I started my laboratory posting during my rheumatology residency, I honestly thought it would be a relatively relaxed month compared to the busy outpatient clinics and wards. But as the posting progressed, I realised it was much more than just a break from clinical work. It gave me the opportunity to understand the science behind the investigations that we order every day. I began to see laboratory reports not just as positive or negative results, but as the outcome of carefully performed procedures that require precision, quality control and proper interpretation.

The posting was a great mix of practical sessions and interactive teaching. We were exposed to a wide range of laboratory techniques, including ANA testing, ELISA, nephelometry, Western blotting, direct and indirect Coombs tests, DHR assay, DNA and RNA extraction, PCR, RT-PCR, HLA-B27 testing, T-cell subset analysis, lymphocyte proliferation assays, immunoline assays and even nerve conduction studies and electromyography. Along with the hands-on training, our faculty explained where each test fits into clinical practice, which made the learning much more meaningful.

One of the biggest lessons I learnt was what actually goes into generating a laboratory report. As clinicians, we usually focus on the final result without thinking about the process behind it. Watching each test being performed helped me understand the importance of proper sample collection, calibration, quality control and the many factors that can affect the final result. This has made me more confident while interpreting reports and has also reminded me to always correlate laboratory findings with the patient’s clinical picture.

Perhaps the most valuable aspect of the posting was seeing these principles play out in real clinical situations. In one case, a nephrology ICU consultation was sought for a purpuric rash in a patient with renopulmonary syndrome. ANA, ENA and ANCA were negative, while an isolated low C4 raised the possibility of cryoglobulinemia. This prompted targeted evaluation for cryoglobulins and ultimately led to the diagnosis of cryoglobulinemic vasculitis. The case reinforced how a seemingly nonspecific laboratory abnormality can become an important diagnostic clue when interpreted in the right clinical context.

Another memorable experience involved a patient with persistent transaminitis and subtle muscle weakness who was initially being evaluated and treated as having liver disease. Viral hepatitis and autoimmune hepatitis markers were negative. However, the disproportionate elevation of AST compared with ALT, together with the history of weakness, raised the possibility that the apparent “transaminitis” was actually muscle-derived. CPK and a myositis panel were therefore requested, leading to the diagnosis of inflammatory myositis. This taught me to look beyond the label attached to a laboratory abnormality and to understand the biological source of the enzyme being measured.

These experiences also changed the way I think about negative laboratory results. Every test can be affected by pre-analytical, analytical and post-analytical factors. Problems such as improper sample collection, inappropriate temperature, delayed transport, haemolysis, storage issues or technical errors can influence the final report. A negative result therefore does not always exclude disease, particularly when the pre-test probability remains high. At times, the most important diagnostic step is not ordering another test, but recognising that the first result may not adequately reflect the underlying disease.

The posting also improved my clinical judgement. Rheumatology depends heavily on investigations, but laboratory tests can never replace a good clinical assessment. Autoantibodies, complement levels, inflammatory markers and molecular investigations are useful only when interpreted in the right clinical context. Learning about ANA patterns, ELISA, immunoblot techniques and other assays reinforced the idea that a positive test alone does not confirm a diagnosis, just as a negative test does not always rule it out.

The molecular diagnostics sessions were particularly interesting. Performing DNA and RNA extraction, PCR, RT-PCR and HLA-B27 testing helped me appreciate the work that goes into these investigations. We often read about these techniques in textbooks, but seeing every step in the laboratory made me realise how much care and accuracy are required to produce reliable results. It also highlighted the growing role of molecular diagnostics in rheumatology, especially in spondyloarthritis, primary immunodeficiency disorders and research.

Another interesting part of the posting was learning about cellular immunology. Sessions on T-cell subset analysis, lymphocyte proliferation assays and investigations for primary immunodeficiency helped me connect basic immunology with clinical rheumatology. It became easier to understand disease mechanisms and also the scientific basis of many targeted therapies that we now use routinely.

The posting also taught me the importance of ordering investigations wisely. Understanding the strengths and limitations of different tests, along with their sensitivity and specificity, helps us avoid unnecessary investigations. Rational test utilisation not only improves diagnostic accuracy but also reduces costs and prevents unnecessary anxiety for patients.

One of the most enjoyable aspects of the posting was working closely with laboratory scientists, technicians and faculty members. Their dedication, attention to detail and commitment to quality showed me how much effort goes into every report that reaches a clinician. It reminded me that patient care is truly a team effort, and good communication between clinicians and laboratory professionals is essential for accurate diagnosis.

Looking back, this laboratory posting has changed the way I approach investigations in rheumatology. It has strengthened my understanding of immunology, improved my interpretation of laboratory reports and enhanced my clinical reasoning. More importantly, it has taught me to always interpret investigations in the context of the patient rather than relying on numbers alone.

The laboratory may seem far away from the bedside, but this posting showed me how closely the two are connected. Good clinical judgement remains the foundation of diagnosis, but understanding how laboratory investigations are performed makes that judgement much stronger. For me, this posting was much more than a part of the residency curriculum. It was a valuable learning experience that I am sure will continue to influence my practice throughout my career as a rheumatologist.